Company plans to drive organic growth across its existing clinic network
INVO Fertility continues to evaluate acquisition opportunities for established, profitable fertility clinics
Company investing in operations, HR, and finance to support expansion and improve scalability
Overview
US fertility clinic operator's Q2 revenue rose 17% yr/yr, driven by acquisitions and organic growth
Net income turned positive, aided by a gain on Birmingham clinic remeasurement
Adjusted EBITDA remained negative at -$1.0 mln, reflecting ongoing platform investments
Key details
Metric
Actual
Q2 Revenue
$2.18 mln
Q2 Net Income
$888,740
Q2 Adjusted EBITDA
-$1.03 mln
Result drivers
Family Beginnings acquisition - Q2 revenue growth was primarily attributed to the addition of Family Beginnings following its February 2026 acquisition
Organic clinic growth - Continued growth initiatives at Wisconsin Fertility Institute and the Georgia clinic contributed to first-half revenue
